Articles On Medlab Clinical (ASX:MDC)
Title | Source | Codes | Date |
---|---|---|---|
Check Up: As Omicron rages, rapid antigen testing specialist Atomo surges nearly 50pc
At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform... |
Stockhead | MDC | 2 years ago |
Sean Hall from Medlab Clinical - Switzer Small and Micro Investor day 2021
Sean Hall of Medlab Clinical speaks at the Switzer Small and Micro Cap Investor Strategy Day 2021. |
Switzer | MDC | 2 years ago |
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %... |
Stockhead | MDC | 2 years ago |
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021
The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19 ravaged the world. Nasdaq-listed BioNTech, which... |
Stockhead | MDC | 2 years ago |
What’s the best pot stock of 2021? And who’s targeting market domination in 2022?
The Australian medicinal cannabis market has seen strong growth in 2021, with revenue from product sales estimated at $230 million. And medical cannabis prescriptions are at an all-time high. The TGA said 13,666 Australian patients were app... |
Stockhead | MDC | 2 years ago |
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables
It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont... |
Stockhead | MDC | 2 years ago |
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health
It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining. Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M... |
Stockhead | MDC | 2 years ago |
Weed Week: Uber Eats enters Canada’s cannabis market and Montu breaks crowdfunding records
Uber is expanding its horizons, with plans to allow users to order cannabis on its Uber Eats app. Next week the app will list cannabis retailer Tokyo Smoke on its marketplace and customers will be able to place orders on the app – but they... |
Stockhead | MDC | 2 years ago |
ASX Health Stocks: UBI partners with Mayo Clinic, while Medlab jumps 8pc after divestment
The ASX 200 Health Index (XHJ) is down by 1.0% at the time of writing, compared to the broader index which is down by 0.1%. Medical diagnostics company, Universal Biosensors (ASX:UBI), has entered into a collaboration agreement with Mayo Cl... |
Stockhead | MDC | 2 years ago |
Weed Week: Cannabis advent calendars and US Republicans introduce weed bill for veterans
Instead of a chocolate advent calendar this year, Californians can get their hands on a cannabis calendar with edibles, prerolls, grams of flower and four days of cannabis accessories. “We’ve seen the success of unique advent calendars in o... |
Stockhead | MDC | 2 years ago |
ScoPo’s Powerplays: Investors become a ‘little more picky’ as markets continue to push ever higher
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week At the time... |
Stockhead | MDC | 2 years ago |
Medlab Clinical (ASX:MDC) receives US patent for NanoCelle
The US Patent & Trademark Office (USPTO) grants patent protection for Medlab Clinical’s (MDC) NanoCelle technology in the United States NanoCelle is Medlab’s drug delivery nanotechnology that aims to overcome the current obstacles surr... |
themarketherald.com.au | MDC | 2 years ago |
ASX Health: Invex gets ready for Phase 3, Medlab gets US patent. Both jump 13pc this morning
The ASX 200 Health Index (XHJ) is up by 0.40% at the time of writing, compared to the broader index which is higher by 0.30%. Neurology specialist, Invex Therapeutics (ASX:IXC), soared 13% after announcing that it’s about to launch a Phase... |
Stockhead | MDC | 2 years ago |
Market Highlights and 5 ASX Small Caps to watch on Thursday
Wall Street at fresh record highs as Fed begins tapering US stocks closed their fourth consecutive days of new record highs, the longest stretch since October of 2017. It came as the US Fed announced the beginning of its Treasury tapering p... |
Stockhead | MDC | 2 years ago |
Weed Week: Belushi and Aykroyd get the band back together to promote cannabis
Actor Jim Belushi has partnered with – you guessed it – Dan Aykroyd on a tour through Oklahoma’s cannabis industry ahead of a Blues Brothers performance. “We believe that cannabis is one of the great, great medicines that can lead to a path... |
Stockhead | MDC | 2 years ago |
ScoPo’s Powerplays: Reopening brings previously neglected health stocks into play
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week Power says... |
Stockhead | MDC | 2 years ago |
ASX Health Stocks: Truscreen jumps 38% on business update, flagging strong growth in China
The ASX 200 Health Index (XHJ) is up by 1.2% at the time of writing, compared to the broader index which is higher by 1%. Truscreen Group (ASX:TRU) was the best health stock performer, up by 38% after reporting key milestones including the... |
Stockhead | MDC | 2 years ago |
Weed Week: California legalises hemp and Aussie medicinal cannabis use hits all-time high
Last week California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sales of hemp-derived CBD products in the state. Hemp has been legalised at the US federal level since 2018, but state agencies have been slow... |
Stockhead | MDC | 2 years ago |
Closing Bell: ASX has its best day of the year, but not enough to avoid 3pc dip in September
The ASX finished September on a solid note but not enough to avoid the worst month since March 2020. The ASX 200 closed at 7,332 points which was 1.88% higher than yesterday but nearly 3% lower than it started the month at. However it is up... |
Stockhead | MDC | 2 years ago |
Weed Week: Amazon scraps marijuana drug tests and Victorian council considers cannabis crops
Retail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired for testing positive for marijuana to reapply for jobs. The company has now excluded marijuana from its comprehensive pre-employment drug scr... |
Stockhead | MDC | 2 years ago |
Weed Week: Cannabis-infused drinks market could reach US$2.8 billion by 2025
The Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused drinks in Canada with the help of Australian listed Althea Group Holdings’ (ASX:AGH) subsidiary. Peak processing Solutions will research and d... |
Stockhead | MDC | 2 years ago |
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August
Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat... |
Stockhead | MDC | 2 years ago |
Best calls to action – Wednesday, 1 September
Today, Wednesday the 1st of September, we are happy to buy Bluebet Holdings Ltd (ASX:BBT), Regis Resources (ASX:RRL), Sandfire Resources (ASX:SFR), Motorcycle Hldg (ASX:MTO), Regis Healthcare Ltd (ASX:REG), Panoramic Resources (ASX:PAN) and... |
Morgans | MDC | 2 years ago |
FNArena Corporate Results Monitor – 01-09-2021
Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((BBT)) - BlueBet Holdings ((BUB)) - Bubs Australia ((BWX)) - BWX ((CRW)) - Cashrewards ((CMW)) - Cromwell Property ((DCN)) - Dacian Gold ((EOS)) - Electro Optic Systems (... |
FNArena | MDC | 2 years ago |
Weed Week: Cannabis trade shows and Europe imports medicinal marijuana
Virginia is the latest US state to legalise marijuana and they’re celebrating with the first annual CannaFest VA cannabis trade show on September 19. The event will feature a concert, and a custom car and motorcycle exhibition but no, you c... |
Stockhead | MDC | 2 years ago |
Closing Bell: ASX climbs again as tech, mining stocks rally
Local markets continued their strong form on Wednesday as the ASX rose for the third straight session. Reporting season threw up some big-name winners as markets responded to the latest round of full-year results. While the ASX 200 edged hi... |
Stockhead | MDC | 2 years ago |
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N... |
Stockhead | MDC | 2 years ago |
Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025
Massachusetts based cannabis operator MariMed has just announced a joint collaboration with the legendary Boston ice cream brand Emack & Bolio’s® to create a line-up of cannabis-infused vegan and dairy ice cream. The ice cream will cont... |
Stockhead | MDC | 2 years ago |
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing
The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du... |
Stockhead | MDC | 2 years ago |
Weed Week: Cannabis business degrees, cornering Germany’s €200M market and Hanks Kerchiefs hits stores
The Community College of Denver (CCD) has just launched a cannabis business program in Colorado. The new program offers students the opportunity to earn an Associate of Applied Science degree designed to prepare them to become business mana... |
Stockhead | MDC | 2 years ago |
Closing Bell: ASX 200 extends gains despite more COVID cases
Australian shares have extended gains for the second day in a row, rising by 0.91% despite more COVID cases across states. All 11 sectors were in the green, except for Healthcare. Mining and Energy led the gains, rising by 2% each, buoyed b... |
Stockhead | MDC | 2 years ago |
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down
It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by Rhinomed (ASX:RNO)... |
Stockhead | MDC | 2 years ago |
Weed Week: The CanCoin, cannabis tourism, and record medicinal product sales in Australia
This week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannabis token designed to solve market friction and monetisation in the European cannabis market and to help build blockchain-based solutions for... |
Stockhead | MDC | 2 years ago |
The hottest stocks trending on Monday
Summary Australian Ethics grants approval for Medlab’s NanaBis™ PIII Australian Sites Live Verdure launches first TGA registered product, shares zoom up Fertoz at over 6-1/2-year high on new partnerships for carbon unit The S&am... |
Kalkine Media | MDC | 2 years ago |
ASX rises over 1% on miner, energy boost; NRW, Viva, BHP lead
Summary The S&P/ASX200 gained as much as 1.1% to 7,353 on Monday. The market witnessed a surge in buying, led by miners, banks, and energy stocks. Seven of 11 sectors were trading in green, led by materials with 2.25% gain. NRW H... |
Kalkine Media | MDC | 2 years ago |
ScoPo’s Powerplays: Quarterlies to dictate price moves, as Nanosonics and Neuren come into play
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week Healthcare fi... |
Stockhead | MDC | 2 years ago |
Check up: A mixed bag for ASX health stocks as FDA decides fates at the flip of a coin
It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals... |
Stockhead | MDC | 2 years ago |
Medlab Clinical talks upcoming Phase III NanaBis trial and NanoCelle partnering opportunities
|
Proactive Investors | MDC | 2 years ago |
Weed Week: Amazon all-in on marijuana; free joints for jabs and Creso Pharma dual-listed in US
The US cannabis sector received a big lift after Amazon announced that job applicants at its offices and warehouses will no longer be drug-tested for marijuana use. Delivery drivers, however, will still be tested. The company also said it w... |
Stockhead | MDC | 2 years ago |
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed
Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U... |
Stockhead | MDC | 2 years ago |
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
There was plenty of action in the US regulatory front within the cannabis sector this week. A couple of major legislations during the week could potentially shake up the US cannabis industry. The Marijuana Opportunity Reinvestment and Expun... |
Stockhead | MDC | 2 years ago |
‘Tidal wave of demand’: There’s a pot shortage in New York
The outlook of the the ‘Horizons Marijuana Life Sciences Index ETF’ (HMMJ) staged a comeback last week — showing a 25.13% gain after suffering a steep decline earlier this month — while news broke that New York and New Jersey may be facing... |
Stockhead | MDC | 2 years ago |
Weed Week: Europe or North America, where’s the place to be for ASX cannabis stocks?
In 2021, which of Europe and North America is the place to be for ASX cannabis stocks? The case for Europe A few years ago there would’ve been no question that it was North America with Canada legalising recreational cannabis as well as h... |
Stockhead | MDC | 2 years ago |
Weed Week: Finally, a cannabis drug is on Australia’s Pharmaceutical Benefits Scheme
A cannabis-based drug has been listed on Australia’s Pharmaceutical Benefits Scheme for the first time, as medical marijuana gains increased acceptance. The move means that an estimated 116 Aussies with a rare form of epilepsy known as Drav... |
Stockhead | MDC | 2 years ago |
Capital Raisings Recap: Nearly $10 billion has already been raised in 2021
The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues.... |
Stockhead | MDC | 2 years ago |
Hot Money Monday: Rumble Resources is the hottest stock on the ASX in the last fortnight
The “hottest ASX stock” – in other words, the stock with the highest RSI – this week is Rumble Resources (ASX:RTR). Each week Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a t... |
Stockhead | MDC | 3 years ago |
Weed Week: 4/20 can’t help ASX cannabis companies
April 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually low. Of the 36 pot companies in the space, 27 have lost ground over the last fortnight. Just seven have advanced. Gains were led by Wide Open... |
Stockhead | MDC | 3 years ago |
Health House Seals Distribution Deal for Dragonfly Medicinal Cannabis Products
Summary Health House International has signed a non-exclusive distribution agreement with Dragonfly Biosciences. The agreement with Dragonfly would strengthen Health House’s product portfolio within Australia. The distribution agreeme... |
Kalkine Media | MDC | 3 years ago |
Why are Australian cannabis shares APH and LGP on the rise?
Source: photolona, Shutterstock Summary Australian Primary Hemp has signed another retail distribution agreement with Coles Group Limited. Cannabis player Little Green Pharma has entered into a non-exclusive distribution agreement wit... |
Kalkine Media | MDC | 3 years ago |
Virginia first southern US state to legalise cannabis, ASX-listed Medlab gets first nod from Europe patent office
The Horizons Marijuana Life Sciences Index ETF (HMMJ) ebbed lower this week after rebounding at the start of the April — while still exceeding its six month performance by more than 80% — despite news that lawmakers in Virginia have elected... |
Stockhead | MDC | 3 years ago |